Xinming Su
Xinming Su
Geverifieerd e-mailadres voor
Geciteerd door
Geciteerd door
Tumor microenvironments direct the recruitment and expansion of human Th17 cells
X Su, J Ye, EC Hsueh, Y Zhang, DF Hoft, G Peng
The journal of immunology 184 (3), 1630-1641, 2010
Human tumor‐infiltrating Th17 cells have the capacity to differentiate into IFN‐γ+ and FOXP3+ T cells with potent suppressive function
J Ye, X Su, EC Hsueh, Y Zhang, JM Koenig, DF Hoft, G Peng
European journal of immunology 41 (4), 936-951, 2011
Hedgehog signaling inhibition blocks growth of resistant tumors through effects on tumor microenvironment
E Heller, MA Hurchla, J Xiang, X Su, S Chen, J Schneider, KS Joeng, ...
Cancer Research 72 (4), 897-907, 2012
The ADP receptor P2RY12 regulates osteoclast function and pathologic bone remodeling
X Su, DH Floyd, A Hughes, J Xiang, JG Schneider, O Uluckan, E Heller, ...
The Journal of Clinical Investigation} 122 (10), 3579-3592, 2012
Dickkopf-related protein 1 (Dkk1) regulates the accumulation and function of myeloid derived suppressor cells in cancer
L D’Amico, S Mahajan, AH Capietto, Z Yang, A Zamani, B Ricci, ...
Journal of Experimental Medicine 213 (5), 827-840, 2016
Stromal-initiated changes in the bone promote metastatic niche development
X Luo, Y Fu, AJ Loza, B Murali, KM Leahy, MK Ruhland, M Gang, X Su, ...
Cell reports 14 (1), 82-92, 2016
Breast and pancreatic cancer interrupt IRF8-dependent dendritic cell development to overcome immune surveillance
MA Meyer, JM Baer, BL Knolhoff, TM Nywening, RZ Panni, X Su, ...
Nature communications 9 (1), 1-19, 2018
Antagonism of inhibitor of apoptosis proteins increases bone metastasis via unexpected osteoclast activation
C Yang, JL Davis, R Zeng, P Vora, X Su, LI Collins, S Vangveravong, ...
Cancer discovery 3 (2), 212-223, 2013
Antagonizing integrin β3 increases immunosuppression in cancer
X Su, AK Esser, SR Amend, J Xiang, Y Xu, MH Ross, GC Fox, ...
Cancer research 76 (12), 3484-3495, 2016
CXCR4 protein epitope mimetic antagonist POL5551 disrupts metastasis and enhances chemotherapy effect in triple-negative breast cancer
J Xiang, MA Hurchla, F Fontana, X Su, SR Amend, AK Esser, GJ Douglas, ...
Molecular cancer therapeutics 14 (11), 2473-2485, 2015
Radionuclides transform chemotherapeutics into phototherapeutics for precise treatment of disseminated cancer
N Kotagiri, ML Cooper, M Rettig, C Egbulefu, J Prior, G Cui, P Karmakar, ...
Nature communications 9 (1), 1-12, 2018
Bone-induced expression of integrin β3 enables targeted nanotherapy of breast cancer metastases
MH Ross, AK Esser, GC Fox, AH Schmieder, X Yang, G Hu, D Pan, X Su, ...
Cancer research 77 (22), 6299-6312, 2017
Whole genome sequence of multiple myeloma-prone C57BL/KaLwRij mouse strain suggests the origin of disease involves multiple cell types
SR Amend, WC Wilson, L Chu, L Lu, P Liu, D Serie, X Su, Y Xu, D Wang, ...
PloS one 10 (5), e0127828, 2015
EGF-recruited JunD/c-fos complexes activate CD2AP gene promoter and suppress apoptosis in renal tubular epithelial cells
C Lu, W Ren, XM Su, JQ Chen, SH Wu, GP Zhou
Gene 433 (1-2), 56-64, 2009
(Key Laboratory of Animal Disease Diagnostic & Immunology, Ministry of Agriculture of People’Republic of China, Nanjing Agricultural University, Nanjing 210095, China …
Virologica Sinica 6, 2004
Inhibition of the stromal p38MAPK/MK2 pathway limits breast cancer metastases and chemotherapy-induced bone loss
B Murali, Q Ren, X Luo, DV Faget, C Wang, RM Johnson, T Gruosso, ...
Cancer research 78 (19), 5618-5630, 2018
CD4+ T cells induce rejection of urothelial tumors after immune checkpoint blockade
Y Sato, JK Bolzenius, AM Eteleeb, X Su, CA Maher, JK Sehn, VK Arora
JCI insight 3 (23), 2018
Dual-therapy with αvβ3-targeted Sn2 lipase-labile fumagillin-prodrug nanoparticles and zoledronic acid in the Vx2 rabbit tumor model
AK Esser, AH Schmieder, MH Ross, J Xiang, X Su, G Cui, H Zhang, ...
Nanomedicine: Nanotechnology, Biology and Medicine 12 (1), 201-211, 2016
Establishment and application of PCR to detect Wild-type pseudorabies virus
Z Bin, SU Xin-ming, Z Su-fang, JIA Yun, CAO Rui-bing, C Pu-yan
Virologica Sinica 19 (6), 612-615, 2004
HTLV-1 viral oncogene HBZ induces osteolytic bone disease in transgenic mice
AK Esser, DA Rauch, J Xiang, JC Harding, NA Kohart, MH Ross, X Su, ...
Oncotarget 8 (41), 69250, 2017
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20